Recessive dystrophic epidermolysis bullosa, also called RDEB, is one form of epidermolysis bullosa. Epidermolysis bullosa is a rare genetic condition that causes very fragile skin. With RDEB, even a ...

The BMJ is an international peer reviewed medical journal and a fully "online first" publication. Our publishing model–"continuous publication"– means that all articles appear on bmj.com before being ...

Dear Dr. Roach • I had an MRA scan, and it was noted that I have calcifications in my cerebellum, suggesting dystrophic calcifications. Is this hereditary? How do you know you have it? — D.S. Answer • ...

Credit: Krystal Biotech. Vyjuvek is a topical HSV-1 vector-based gene therapy. The Food and Drug Administration (FDA) has approved Vyjuvek ™ (beremagene geperpavec-svdt) for the treatment of wounds in ...

Beremagene geperpavec-svdt (B-VEC) entered the market in 2023 as the first approved corrective treatment for dystrophic epidermolysis bullosa (DEB), a rare genetic disease affecting the skin and nails ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with recessive dystrophic epidermolysis bullosa. The approval is based on the pivotal ...

I had an MRA scan, and it was noted that I have calcifications in my cerebellum, suggesting dystrophic calcifications. Is this hereditary? How do you know you have it? – D.S. Dr. Roach: Calcifications ...

Dystrophic epidermolysis bullosa is a rare genetic blistering skin disease caused by mutations in COL7A1, which encodes type VII collagen (C7). Beremagene geperpavec (B-VEC) is a topical ...

Focal adhesion (FA) proteins may be critical elements in the production of dystrophic neurites in Alzheimer's disease, according to research presented in the January 15 Journal of Neuroscience. Recent ...

Dear Dr. Roach: I had an MRA scan, and it was noted that I have calcifications in my cerebellum, suggesting dystrophic calcifications. Is this hereditary? How do you know you have it? - D.S. Answer: ...